Mylan Will Begin Marketing New Generic Oral Contraceptive Portfolio In 2010

Mylan Pharmaceuticals will enter the generic women's health care market with a portfolio of 22 oral contraceptive products acquired through a development and supply agreement with India-based Famy Care